Komipharm International Co., Ltd is a leading specialist in animal medicine, offering a wide range of products such as animal vaccines, preventive vaccines, food preservatives, and anti-cancer drugs. They also provide human pharmaceuticals. With a focus on research and development, Komipharm aims to contribute to the improvement of the health and quality of life for both humans and animals.

They strive to become a global leader in the bio-industry by leveraging their research ecosystem and innovative approach to global expansion. Komipharm's animal pharmaceutical business is at the forefront, with a strong potential for growth and a bold presence in international markets. They adhere to stringent pharmaceutical management standards and supply exceptional products domestically and internationally.

Additionally, their R&D efforts include developing new treatments for cancer-related pain and autoimmune therapy. Komipharm is dedicated to enhancing the quality of life for all living beings and aims to be a frontrunner in the global bio industry